to GoldmanSachs, anybody? Ronin should formulate a spin-off
... for the kit manufacturing and marketing operation, placed off-shore for cost and tax advantagse (the parent can always "loan those excess profits") and get a fair and instant valuation with an IPO.
Such IPO does then reflect on the PPHM share price by reference, not to mention the (for Peregrine) enormous publicity in a new a stock offer, and thus potentially accelerating the Exosome markets and even a future Bavi partnering.
See my valuation on Exosome -- the comments so far have been overwhelming, but Time is marching on, we need PPHM value now.
And I for one, no longer get enough entertainment value out of the Bavi-babble. Show me the SP!